Liothyronine Sodium
NDC 59762-1206, liothyronine sodium, tablet, from Mylan Pharmaceuticals Inc..
- Product NDC
- 59762-1206
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA010379
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1206 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM5 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59762-1206-1 | 59762120601 | 100 TABLET in 1 BOTTLE (59762-1206-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/115a84c2-0126-4dd7-816e-1873875f1e49NADAC price for package 59762120601
GET /v1/drugs/nadac/59762120601
Use it
Look up 59762-1206 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1206 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59762-1206. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.